Isolation of unexplored frontier molecules are needed to treat multidrug resistant pathogens especially Methicillin resistant Staphylococcus aureus (MRSA). A marine sponge endosymbiotic Streptomyces albus ICN33 produces an anti-MRSA metabolite is reported. The crude extract exhibited anti-MRSA activity and the active principle was isolated through fermentation and chromatographic techniques. A compound PVI331 with a molecular mass of 506 Da have been determined by high resolution mass spectrometry. LC–MS based dereplication analysis had revealed that the detected compound PVI331 as unknown. The antibacterial assay of the compound PVI331 showed remarkable antagonistic activity against MRSA and Escherichia coli. Minimum inhibitory concentrations were found to be 1 μg/ml against MRSA. Sub-inhibitory concentration of the compound PVI331 reduced the biofilm formation of Staphylococcus aureus ATCC25923 and increased the cell surface hydrophobicity index. Scanning electron microscopic observation of the sub-inhibitory concentration exposure revealed a wrinkled membrane surface and slight cellular damage shows the cell wall distracting property of the compound. Zebrafish embryo based toxicity assays exhibited 48 ± 2 μg/ml of LC50 value and 30 μg/ml of compound as maximal non-lethal concentration which had demonstrated the positive relationship in safety index. This study highlighted the anti-MRSA property of Streptomyces albus ICN33 from a marine sponge.

International Centre for Nanobiotechnology Manonmaniam Sundaranar University Rajakkamangalam 629502 Kanyakumari District TN India

Molecular and Nanomedicine Research Unit Centre for Nanoscience and Nanotechnology Sathyabama University Jeppiaar Nagar Chennai 600119 TN India

Citace poskytuje Crossref.org

Literatura